14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 2.719 42 days ( -88.17 % )
Last Price $3.50 6.38 %
High/ Low $3.20 - $3.55 9.38%
Chg 7 Days 3.55 % $3.38 $3.50
Chg 30 Days 47.68 % $2.37 $3.50
Chg 12 mos 98.86 % $1.76 $3.50
Trend - 3 mos 96.05 % Width: 50.75 %
Trend - 12 mos 33.56 % Width: 131.91 %
Pred. range - 3 mos $5.93 - $8.94 69.44 % - 155.44 %
Pred. range - 12 mos $2.44 - $5.67 -30.19 % - 61.89 %
Short MA avg 3 mos Buy Apr 24, 2024 - 2 days
Long MA avg 3 mos Buy Feb 13, 2024 - 51 days
Short/Long MA avg 3 mos Buy Feb 20, 2024 - 47 days
Short MA avg 12 mos Sell Apr 19, 2024 - 5 days
Long MA avg 12 mos Sell Feb 26, 2024 - 43 days
Short/Long MA avg 12 mos Buy Mar 08, 2024 - 34 days
Pivot Short Sell Apr 11, 2024 - 11 days
Bollinger Buy Mar 20, 2024 - 26 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Galectin Therapeutics Inc.

Galectin Therapeutics. Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatiti... GALT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT